COVID-19 microscopic image

Research to

Combat Emerging Infectious Diseases

Soldier Health. World Health.

Interactive world map with highlighted regions

Who We Are

The Emerging Infectious Diseases Branch (EIDB) at the Walter Reed Army Institute of Research leads efforts to anticipate, prepare for and rapidly respond to infectious disease threats through an accelerated, iterative cycle of countermeasure development — from conception through human clinical trials.

Learn More

Dr. Kayvon Modjarrad and Dr. Gordon Joyce discuss EIDB's strategic approach to the COVID-19 vaccine, SpFN, developed at the Walter Reed Army Institute of Research.


SpFN particle graphic

A series of recently published preclinical study results show that the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research may provide broad protection against SARS-CoV-2 variants of concern as well as other coronaviruses.